Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety.

Jones GM, Murphy CV, Gerlach AT, Goodman EM, Pell LJ.

Ann Pharmacother. 2011 Jun;45(6):740-7. doi: 10.1345/aph.1P726. Epub 2011 Jun 10.

PMID:
21666095
2.

The use of dexmedetomidine in anesthesia and intensive care: a review.

Farag E, Argalious M, Abd-Elsayed A, Ebrahim Z, Doyle DJ.

Curr Pharm Des. 2012;18(38):6257-65. Review.

PMID:
22762468
3.

Dexmedetomidine: an updated review.

Gerlach AT, Dasta JF.

Ann Pharmacother. 2007 Feb;41(2):245-52. Epub 2007 Feb 13. Review. Erratum in: Ann Pharmacother. 2007 Mar;41(3):530-1.

PMID:
17299013
4.

Prolonged infusions of dexmedetomidine in critically ill patients.

Guinter JR, Kristeller JL.

Am J Health Syst Pharm. 2010 Aug;67(15):1246-53. doi: 10.2146/ajhp090300. Review.

PMID:
20651314
5.

Optimizing sustained use of sedation in mechanically ventilated patients: focus on safety.

Arnold HM, Hollands JM, Skrupky LP, Mice ST.

Curr Drug Saf. 2010 Jan;5(1):6-12. Review.

PMID:
20210713
6.

Use of dexmedetomidine in the adult intensive care unit.

Wujtewicz M, Maciejewski D, Misiołek H, Fijałkowska A, Gaszyński T, Knapik P, Lango R.

Anaesthesiol Intensive Ther. 2013 Oct-Dec;45(4):235-40. doi: 10.5603/AIT.2013.0045. Review.

7.

An updated focused review of dexmedetomidine in adults.

Gerlach AT, Murphy CV, Dasta JF.

Ann Pharmacother. 2009 Dec;43(12):2064-74. doi: 10.1345/aph.1M310. Review.

PMID:
19934395
8.

Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review.

Cruickshank M, Henderson L, MacLennan G, Fraser C, Campbell M, Blackwood B, Gordon A, Brazzelli M.

Health Technol Assess. 2016 Mar;20(25):v-xx, 1-117. doi: 10.3310/hta20250. Review.

9.

Dexmedetomidine: pediatric pharmacology, clinical uses and safety.

Su F, Hammer GB.

Expert Opin Drug Saf. 2011 Jan;10(1):55-66. doi: 10.1517/14740338.2010.512609. Epub 2010 Aug 18. Review.

PMID:
20718689
10.

Dexmedetomidine: a review of clinical applications.

Carollo DS, Nossaman BD, Ramadhyani U.

Curr Opin Anaesthesiol. 2008 Aug;21(4):457-61. doi: 10.1097/ACO.0b013e328305e3ef. Review.

PMID:
18660652
11.

Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine.

Szumita PM, Baroletti SA, Anger KE, Wechsler ME.

Am J Health Syst Pharm. 2007 Jan 1;64(1):37-44. Review.

PMID:
17189578
12.
13.

Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.

Baddigam K, Russo P, Russo J, Tobias JD.

J Intensive Care Med. 2005 Mar-Apr;20(2):118-23. Review.

PMID:
15855224
14.
15.

Dexmedetomidine: new insights.

Mantz J, Josserand J, Hamada S.

Eur J Anaesthesiol. 2011 Jan;28(1):3-6. doi: 10.1097/EJA.0b013e32833e266d. Review.

PMID:
20881501
16.

Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta-analysis of randomized clinical trials.

Xia ZQ, Chen SQ, Yao X, Xie CB, Wen SH, Liu KX.

J Surg Res. 2013 Dec;185(2):833-43. doi: 10.1016/j.jss.2013.06.062. Epub 2013 Jul 24. Review.

PMID:
23910886
17.

Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.

Brotherton AL, Hamilton EP, Kloss HG, Hammond DA.

Pharmacotherapy. 2016 Apr;36(4):433-42. doi: 10.1002/phar.1726. Epub 2016 Apr 1. Review.

PMID:
26893017
18.

Dexmedetomidine.

Coursin DB, Coursin DB, Maccioli GA.

Curr Opin Crit Care. 2001 Aug;7(4):221-6. Review.

PMID:
11571417
19.

Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients.

Oschman A, McCabe T, Kuhn RJ.

Am J Health Syst Pharm. 2011 Jul 1;68(13):1233-8. doi: 10.2146/ajhp100257. Review.

PMID:
21690429
20.

Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients.

Mo Y, Zimmermann AE.

Ann Pharmacother. 2013 Jun;47(6):869-76. doi: 10.1345/aph.1AR708. Review.

PMID:
23719785

Supplemental Content

Support Center